The page is the record's research on the issuer — no analyst, no rating, no view. # aTYR PHARMA INC (NASDAQ: ATYR) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is aTYR PHARMA INC, listed on NASDAQ under ticker ATYR, with ISIN US0021202025 and LEI 529900ENQUXMC5EBKO36. The security type is Corporate. The segment is not on the record. The sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The listing status is listed, not halted. ## The disclosure read The record holds 47 filings in the window 2025-11-08 to 2026-11-08, across 28 filing days. The median gap between filing days is 8 days. The latest filing is dated 2026-11-06, a corporate_news filing, 2 days before the record date of 2026-11-08. The NASDAQ median gap between filing days is 6.0 days, with a median of 52 filings and a median latency of 5.0 days. The sector median gap is 5.5 days, with a median of 65.5 filings and a median latency of 4.0 days. By type, the window holds 15 directors_dealings, 9 regulatory_filing, 9 results, 6 agm_egm, 3 corporate_news, 2 ad_hoc, 2 halt_suspension and 1 prospectus. ## Auditor The auditor of record is Ernst & Young LLP, located in San Diego, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://data.sec.gov/submissions/CIK0001339970.json (identity.jurisdiction) - https://api.gleif.org/api/v1/lei-records/529900ENQUXMC5EBKO36 (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/ATYR (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1339970/000133997026000008/atyr-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ATYR (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ATYR · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp